Video

Fellows on Film: Lessons Learned During Oncology Fellowship

Author(s):

Michael L. Grossbard, MDRabi Upadhyay, MD
Video Series|Fellows on Film

Michael L. Grossbard, MD, and Rabi Upadhyay, MD, Instructor, Department of Medicine at NYU Grossman School of Medicine, share their experiences as a fellowship director and an oncology fellow, respectively.

Michael L. Grossbard, MD, and Rabi Upadhyay, MD,
Instructor, Department of Medicine at NYU Grossman School of Medicine, share their experiences as a fellowship director and an oncology fellow, respectively.

Grossbard is professor in the Department of Medicine at NYU Grossman School of Medicine, chief, Hematology and Medical Oncology Inpatient Service, Tisch Hospital, and section chief of hematology, at NYU Langone Health's Perlmutter Cancer Center.

Upadhyay is an instructor in the Department of Medicine at NYU Langone Health's Perlmutter Cancer Center.

In this segment, Upadhyay shares some of the lessons he learned during his oncology fellowship at NYU Langone Health's Perlmutter Cancer Center, of which Grossbard was his fellowship director.


Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD
Related Content
David Eagle, MD, chair, legislative affairs and patient advocacy, New York Cancer & Blood Specialists; chair, Advocacy Committee, OneOncology
May 17th 2024

Leveraging Managed Service Organizations to Provide More Affordable, Personalized Cancer Care

Diane M. Simeone, MD; Marwan G. Fakih, MD
December 18th 2023

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

Lora Markley, Director of Regional Managed Care for The US Oncology Network
April 19th 2024

Quality Over Quantity: What Concierge Medicine Can Offer to Patients With Cancer and Employers

Jeffrey S. Weber, MD, PhD
November 6th 2023

FDA Approval Insights: Adjuvant Nivolumab in Completely Resected Stage IIB/C Melanoma

Susan D. Klugman, MD, director, reproductive and medical genetics, program director, medical genetics and genomics, Montefiore Einstein; professor, obstetrics and gynecology and women’s health, Albert Einstein College of Medicine
April 2nd 2024

Patient Insurance Status and Out-of-Pocket Costs Affect Genomic Testing Frequency

Bhavana Pothuri, MD, professor, the Department of Obstetrics and Gynecology, the Department of Medicine, New York University Grossman School of Medicine; director, Gynecologic Oncology Research, medical director, the Clinical Trials Office, director, Gynecologic Oncology Clinical Trials, Perlmutter Cancer Center
March 13th 2024

First-Line Niraparib Maintenance Is Not Associated With Worse HRQOL in Advanced Ovarian Cancer